Compare ADMA Biologics Inc (ADMA) vs Standard Lithium Ltd (SLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Standard Lithium Ltd — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Standard Lithium Ltd trades at $2.41 (market cap $604.50M). The key difference: ADMA Biologics Inc is far larger — about 3.7× Standard Lithium Ltd's market cap. Which is the better fit depends on your goals.
| ADMA | SLI | |
|---|---|---|
Market Cap | $2.22B | $604.50M |
Sector | Health | Basic Materials |
52-Week High | $20.38 | $5.65 |
52-Week Low | $7.60 | $1.93 |
Enterprise Value | $2.29B | $467.42M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Standard Lithium Ltd
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →
